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Abstract
Background: Nearly 20 years after the adoption by the government of Malawi of the provision of intermittent
preventive treatment in pregnancy (IPTp) for malaria, only 55 % of pregnant women received at least two doses of
sulfadoxine-pyrimethamine (SP) in 2010. Although several reasons for the low coverage have been suggested, few
studies have examined the views of health care providers. This study examined the experiences of the nurses and
midwives in providing antenatal care (ANC) services.
Methods: This study was conducted in health facilities in Malawi that provide routine ANC services. Providers of
ANC in Malawi were selected from in eight health care facilities of Malawi. Selected providers were interviewed
using a semi-structured interview guide designed to address a series of themes related to their working conditions
and their delivery of IPTp.
Results: Nurses displayed detailed knowledge of ANC services and the rationale behind them. Nurses understood that
they should provide two doses of IPTp during a pregnancy, but they did not agree on the timing of the doses. Nurses
gave SP as directly observed therapy (DOT) at the clinic. Nurses did not give SP pills to women to take home with
them because they did not trust that women would take the pills. Women who resisted taking SP explained they do
not take drugs if they had not eaten, or they feared side effects, or they were not sick. Reasons for not giving the first
or second dose of SP included a delay in the first ANC visit, testing positive for HIV, and presenting with malaria. None
of the nurses were able to show any specific written guidelines on when to give SP. The challenges faced by the
nurses include being overworked and persuading women to take SP under observation.
Conclusion: The findings show that the nurses had gained the knowledge and technical skills to provide appropriate
ANC services. With regard to IPTp, nurses need guidelines that would be available at the health facility about how and
when to give SP. The adoption of the WHO guidelines and their diffusion to health care facilities could help increase
the coverage of IPTp2 (at least two doses of sulfadoxine-pyrimethamine) in Malawi.
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Background
In countries of sub-Saharan Africa (SSA) where malaria is
endemic, malaria during pregnancy has damaging effects
on the health of mothers, the fetus, and neonates. The
World Health Organization (WHO) has recommended a
package of three interventions to address this danger: pro-
vide antimalarial drugs to prevent malaria during preg-
nancy, sleep under an insecticide-treated net (ITN), and
provide prompt and effective treatment of malaria. Since
the general recognition of the benefits of providing inter-
mittent preventive treatment of malaria during pregnancy
(IPTp) [1–3], many countries in SSA have sought to pro-
vide at least two doses of sulfadoxine-pyrimethamine (SP)
as an integral part of antenatal care (ANC).
The WHO recommendations on IPTp have evolved
over time as more research has shown the safety and ef-
ficacy of giving SP and its important contribution in the
improvement of maternal and newborn health outcomes.
The WHO recommendations of 2004 had stated that
* Correspondence: pstanleyyoder@gmail.com
1ICF International, Rockville, MD, USA
Full list of author information is available at the end of the article
© 2015 Yoder et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yoder et al. BMC Health Services Research  (2015) 15:354 
DOI 10.1186/s12913-015-0986-x
pregnant women should be given SP in the first two
ANC visits after quickening [4]. In 2007 WHO recom-
mended that pregnant women be given two or three
doses of SP after the first trimester of gestation [5]. After
further studies had demonstrated the safety of providing
SP later in pregnancy, WHO revised its policy in 2012 to
recommend that SP be given at every ANC visit after
the first trimester up until the time of delivery with an
interval of one month between doses, [6].
As countries in SSA adopt WHO guidelines and seek
to implement them at national levels, they have set tar-
gets for coverage of at least two doses of IPTp and
sought ways to assess their success. The indicator com-
monly used is the proportion of women who received at
least two doses of SP after the first trimester during their
last pregnancy. The target of African countries set in
2000 was to achieve 60 % coverage with IPTp2 by 2005,
a target achieved by only The Gambia and Zambia [4].
The current target for IPTp2 coverage for all countries
is 80 % by 2015. What challenges do countries face in
reaching that target?
A meta-analysis of national survey data from 2009–2011
of IPTp2 coverage in 22 countries in SSA suggests that the
low coverage of IPTp2 is not likely to be caused by low at-
tendance of ANC clinics since in 20 of 22 countries, more
than 60 % of pregnant women made at least two ANC
visits [1]. An analysis of data on IPTp coverage from the
Demographic and Health Surveys (DHS) in 16 countries in
SSA concluded that the appropriate delivery of IPTp de-
pends more on the dynamics of service delivery than on
any differential access to ANC [7]. A recent review and
meta-analysis of factors affecting the delivery, access, and
use of interventions to prevent malaria in pregnancy in
SSA found that barriers to the provision of IPTp were: 1)
unclear policy and guidance on IPTp, 2) general health
care system issues, (stock-outs and user fees), 3) poor qual-
ity of care, 4) misunderstanding by health care providers of
protocols related to the timing of giving SP, and 5) low
attendance at ANC clinics [8]. Health care provider confu-
sion about the timing of the two doses of SP, and whether
SP can be given on an empty stomach, featured promin-
ently in many publications [2, 9–12].
A number of recent qualitative studies of health care
providers’ experience in delivering IPTp to clients of ANC
services have shown how working conditions and uncer-
tainty about the timing of IPTp contribute to low coverage
of IPTp [9, 13, 14]. Two recent studies of the experiences
of health care providers in Nigeria found that the majority
was confused about national IPTp policy on the timing of
giving IPTp, and most of them did not give SP under dir-
ectly observed therapy (DOT) [2, 10]. Interviews with
health workers in the Ségou region of Mali found that the
health care providers were confused about how and when
to give SP [13].
Antenatal care and IPTp in Malawi
The government of Malawi first adopted a policy of pro-
viding IPTp as part of comprehensive antenatal care in
1993. Ministry of Health guidelines of 1997 recommended
that two doses of SP be given to pregnant women in ANC
clinics: a first dose on the first ANC visit after the first tri-
mester, and the second dose between 28 and 34 weeks
(Ministry of Health and Population. National Malaria Policy
Guidelines. 1997. Unpublished MOH policy document).
The IPTp strategy was revised in 2002 and recommended
that pregnant women be given two doses of SP after the
first trimester at least one month apart under directly ob-
served therapy (DOT) as part of ANC services.
The Ministry of Health guidelines for the provision of
IPTp have changed over time in Malawi, but the various
Ministry divisions did not always make the same recom-
mendations. In 2006 the Ministry of Health adopted a
policy of Focused Antenatal Care (FANC) as part of an es-
sential health care package for maternal health (Ministry
of Health. Focused Antenatal Care and Prevention of
Malaria during Pregnancy. Training Manual for Healthcare
Providers. 2006. Unpublished MOH policy document).
The policy recommends that pregnant women make at
least four ANC visits with the first visit in the first trimes-
ter of gestation. The policy guidelines for the provision of
IPTp presented in the National Reproductive Health
Strategy, 2006–2010 recommended that IPTp be given
at 26 and 32 weeks of gestation (Ministry of Health.
National Reproductive Health Service Delivery Guidelines.
Reproductive Health Unit. 2007. Unpublished policy
document). The National Malaria Treatment Guidelines,
also published in 2007, recommended that at least
three doses of SP be given at least four weeks apart
after the first trimester (Ministry of Health. National
Malaria Treatment Guidelines. Lilongwe: National
Malaria Control Programme; 2007).
The US President’s Malaria Initiative (PMI) requested
a review of Malaria in Pregnancy documents in late
2013 for 19 countries, including Malawi. This review
examined government documents to assess the degree
of coherence and consistency in the guidelines provided
for giving SP. The review found that in Malawi, the
guidelines were unclear and did not follow WHO rec-
ommendations regarding the timing of giving SP, in the
designation of giving SP by specific weeks, and in prohi-
biting the provision of SP after 36 weeks of gestation
[15]. The report also noted that the MOH of Malawi
had formed a Technical Working Group to revise and
standardize guidelines for Malaria in Pregnancy recom-
mendations along the lines suggested by WHO.
In July of 2011 the Ministry began implementation of
a new strategy to test and treat women who test positive
for HIV in ANC clinics [16]. Known as Option B+, the
strategy sought to provide testing, counseling, and anti-
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retroviral therapy (ART) for all HIV+ women within
PMTCT no matter what their CD4 count. The strat-
egy was generated and adopted in a workshop in
April 2011 that involved government officials, private
parties, and international donors [17]. All pregnant
women attending ANC clinics are tested for HIV, and
those who test positive for HIV are encouraged to en-
roll in ART services.
Data from the 2010 Malawi DHS showed that while
95 % of the women had made two or more ANC visits
during the most recent pregnancy, the national IPTp2
coverage was 55 % [17]. Part of the reason that IPTp2
was not higher may be that most pregnant women in the
sample who attended an ANC clinic at least once made
their first visit after the first trimester: 48 % came first
when they were 4–5 months pregnant, and 36 % at 6–7
months of pregnancy. The median number of months of
gestation at the first visit was 5.6 months. Given the rela-
tively high proportion of women who make at least two
ANC visits during a pregnancy, low use of ANC services
does not appear to be a factor in IPTp2 coverage in
Malawi. Other possible explanations for relatively low
coverage of IPTp2 are related to the process of providing
SP within ANC clinics: the actions and understandings of
nurses and midwives, or the knowledge and actions of
women attending ANC services.
Ashwood-Smith and colleagues conducted a study of
the provision of sulphadixine-pyrimethamine (SP) in
pregnancy in Blantyre District of Malawi in 2001 [11].
The study found that the majority of the medical staff
did not understand government guidelines clearly and
were confused by the instructions to give the first dose
during the second trimester and the second in the third
trimester. Similarly, a study by Launiala and colleagues
examined factors that affected compliance with IPTp
guidelines by conducting focus groups and individual inter-
views among Yao women in Machinga district of southern
Malawi. The study found that late enrolment in ANC
clinics, unclear messages from nurses about taking SP, and
the limited understanding of IPTp among women, all lim-
ited the uptake of SP in ANC clinics [12]. Our study covers
topics similar to these studies, but places more emphasis
on the context of service delivery in ANC clinics and on
the perspectives of care providers on their own work.
Methods
Study design
This paper is derived from a slightly wider qualitative
study of the experiences of health care providers who
deliver antenatal services in health facilities in Malawi as
described by the service providers themselves [18]. The
paper focuses on the factors that affect the delivery of
IPTp in the context of ANC services from the perspec-
tives of the nurses and midwives who provide the
services. The study examined the ways in which the
training, the working conditions, the context of ANC
delivery, and the knowledge of government guidelines
for IPTp affected the delivery of SP to pregnant women
in ANC clinics. The specific questions included:
 How do nurses and midwives describe the ANC
services they routinely provide to pregnant women
in ANC clinics?
 What do the nurses and midwives who provide
antenatal services understand about the Ministry of
Health policy on IPTp?
 What do they know about the purpose and
importance of IPTp?
 What has been the experience of nurses and
midwives in providing SP to pregnant women in the
context of ANC services in general?
Study context and setting
This study was designed to complement the data on ANC
services collected by the 2013 Service Provision Assess-
ment (SPA). The 2013-14 SPA in Malawi was developed
as a census of all formal sector health facilities in the
country, including hospitals, health centres, maternities,
dispensaries, and health posts [19]. The survey included
observation of the delivery of ANC services as well as exit
interviews with ANC clients. MOH personnel who were
managing the SPA supported this study by selecting the
health care facilities to be visited, arranging for the actual
visits, and introducing the person conducting the inter-
views to facility directors. Health care services in Malawi
are provided by government health facilities and by facil-
ities managed by the Christian Health Association of
Malawi (CHAM). ANC is provided by nurses and mid-
wives who work in specialized ANC clinics. Health care
facilities provide PMTCT (prevention of mother-to-child
transmission) services as part of standard ANC services.
Ethical clearance
This study was an extension to the Service Provision
Assessment (SPA) implemented in 2013 by the Ministry
of Health (MOH) with technical assistance from ICF
International. The SPA protocol was approved by the
Institutional Review Board of ICF International. The
SPA protocol was also submitted for ethical clearance by
ICF to the Malawi National Health Sciences Research
Committee. The committee determined that the Malawi
SPA was a routine assessment, and therefore did not
need any formal IRB clearance. At the level of data col-
lection within health care facilities, after study objectives
and methods were explained to potential respondents,
informed content was obtained orally from each re-
spondent before the interview began.
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Sample selection
The study assumed that ANC delivery might vary with
the complexity of the medical services delivered, by
whether the facility was administered by the government
or by non-government entities, or by being located in
urban or rural areas. The facilities for the study were
therefore purposively chosen with those variables in
mind. Eight health care facilities in the Central and
Northern regions were visited. The facilities selected
were two regional central hospitals, two district hospi-
tals, and four rural hospitals. The non-government facil-
ities visited were administered by CHAM.
In each facility, at least three health care providers
who routinely provided ANC services were identified.
The research specialist interviewed those three (or four)
individuals with a semi-structured conversation guide.
Table 1 shows the type of facility, the titles of those inter-
viewed, and the specialized training each of the respon-
dents reported [17]. Few respondents reported having
taken any specialized training in IPTp service delivery.
Data collection and analysis
A total of 26 interviews were conducted in eight health fa-
cilities in July and August, 2013. In all cases, the three or
four interviews were conducted during a one-day visit to a
health care facility. All but one of the respondents held
the title of nurse or midwife, or both. The exception was a
clinical officer interviewed at a rural government facility.
Since those with the titles of nurse, of community health
nurse, or of midwife all had similar training as nurses, we
will most often refer to them in this text simply as nurses.
The interviews were guided by a semi-structured con-
versation guide that focused on: 1) the professional train-
ing received; 2) working conditions and responsibilities
within the facility; 3) their knowledge of the rationale for
ANC services, 4) their knowledge of MOH policy on
IPTp, and 5) their experience in providing IPTp as part of
antenatal care. The conversation guide was pre-tested in a
health facility in Lilongwe and then revised to eliminate
repetitions and streamline the questioning process. Inter-
views were conducted in English and recorded with
permission of the respondents (two declined), then tran-
scribed and typed for analysis.
Transcripts were coded manually according to the
themes cited above. The specific topics mentioned under
each theme as well as the relative importance given to
each topic were noted as part of content analysis. Sum-
maries of the accounts of respondents related to each
theme were written to facilitate direct comparison among
the accounts. The amount of variation in the topics dis-
cussed by the respondents was examined to identify the
extent of consistency among the accounts. Special atten-
tion was paid to descriptions of the challenges they faced
in persuading women to take SP at the clinic through dir-
ect observed therapy (DOT).
Results
Professional training, knowledge and work
responsibilities
Most of the respondents had been trained in comprehen-
sive nursing and midwifery, and nearly half had undertaken
training in community health. A few had been trained away
from station for a few days in the prevention of mother to
child transmission of HIV (PMTCT), integrated manage-
ment of childhood illnesses (IMCI), or anti-retroviral ther-
apy (ART). Only two of the respondents reported that they
had received special training in the provision of IPTp.
The nurses, midwives, and clinical officers working in
these health facilities had all been trained to work in any
department of a hospital in addition to providing ANC
services; they indicated that they routinely worked in
various departments of the facility. The nurses in all the
facilities visited expressed concern about staff shortages
and heavy workloads that leaves them exhausted. They
reported that such arrangements lead to staff shortages
in ANC clinics. A nurse in a rural facility expressed frus-
tration about her multiple responsibilities:
Because I am a community health nurse, I am
supposed to work in the community, but in my job
description I am supposed to work anywhere. I can go
to the male ward; I can go to the female ward. I can
go to the labor ward to conduct deliveries.
The consistency in the knowledge shown by each re-
spondent suggests that they were well trained as nurses in
the same curriculum overall. It should also be noted that
they spoke of the work of service provider with enthusi-
asm and with a concern for the interests of their clients,
especially those with high risk pregnancies. They stressed
the importance of giving a thorough ‘head-to-toe examin-
ation’ of ANC clients to identify risky pregnancies and to
discover any abnormality that could be addressed. And
they provided details about their efforts to persuade
women to accept ANC services, especially ART and IPTp.
They spoke of the difficulties some women had to over-
come to attend ANC services: traveling long distances, a
disinterested husband; a young woman very shy about
being examined. They seemed sincere about wanting to
perform well despite often serving for long hours.
Nature of antenatal care services
The health care facilities contacted for this study each of-
fered ANC services five days a week in a unit separate
from other services. The rural facilities had fewer staff per
client, less space, and fewer supplies than did the urban fa-
cilities. ANC services in these hospitals are ostensibly free
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except in the two central regional hospitals where women
pay a fee (about 2.50 US dollars) unless they had been re-
ferred to that facility by another health care entity. One
CHAM facility was charging a fee to mothers who came
from outside its catchment area.
The reports of nurses on the services they provide as
part of ANC varied little in their content. The ANC ser-
vices mentioned include a physical examination, counsel-
ing and screening, basic tests, preventive services, and
medications. Blood pressure and height and weight are
Table 1 Type of health care facility and qualifications of respondents interviewed
Type of facility Type of respondent Qualifications
Regional Central
Hospital Urban
Enrolled nurse and community
nurse-midwife
ART, PMTCT, STI, IDSR, trauma for
patients involved in car accidents
Nurse and midwife technician ART initiation, IPTp, Option B+
Nurse and midwife Care counseling, in-service on SP,





Community nurse and midwife ART, CBMAM, focused ANC, IMCI,
infection prevention, malaria case
management, PMTCT, pneumonia
case management
Nurse and midwife technician ART
CHAM Hospital Rural Registered nurse and midwife ART
Nurse and midwife
Community nurse and midwife FANC, SP
Government Hospital
Rural
Community health nurse Family planning, infection prevention,
supportive supervision
Community health nurse FANC, HIV/AIDS counseling and testing,
PMCT
Community health nurse ART , HIV/AIDS counseling and testing
CHAM Hospital Rural Community nurse technician ARV, counseling, family planning, FANC,
PMTCT, SP, tuberculosis management




Nurse and midwife technician Family planning, FANC, infection prevention
reproductive health, VIA
Nurse and midwife technician
Nurse and midwife technician
Nurse and midwife technician FANC, PMTCT, STI, VIA
Government Hospital
Semi-urban




Community health nurse ARI, ART, CMAM, community mobilization,
ETAT, FANC, integrated community-based




Nurse and midwife technician FANC, intensive training in HTC, PMTCT,
safe motherhood
Nurse and midwife technician
Nurse and midwife technician IMCI, integrated ART, PMTCT, youth-friendly
services
ANC antenatal care, ARI acute respiratory infection, ART antiretroviral therapy, ARV antiretroviral, CBMAM community based management of acute malnutrition,
CMAM community management of acute malnutrition, ETAT emergency triage and assessment treatment, FANC focused antenatal care, HTC HIV testing and
counseling, IDSR integrated disease surveillance and Response, IMCI integrated management of childhood illnesses, IPTp intermittent preventive treatment in
pregnancy, PMTCT prevention of mother-to-child transmission, SP sulfadoxine-pyrimethamine, STI sexually transmitted infection
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recorded, and blood and urine are taken for basic tests.
Test results as well as services received are recorded in a
booklet women have purchased or been given called a
“health passport” that serves as a record of their contacts
with health services. The preventive services include tet-
anus toxoid vaccines, a drug for intestinal parasites,
screening for anemia and the delivery of iron supplements,
counseling and testing for HIV, and IPTp. Women are
counseled about the danger signs of complicated preg-
nancy, about protecting themselves against HIV transmis-
sion, and about the benefits of taking sulfadoxine-
pyrimethamine (SP). Women considered especially vulner-
able for high risk pregnancies receive special attention:
women younger than 18, those who are very short, those
who have had any sort of an operation, and those with a
physical handicap.
The nurses explained that the two ANC services that
demand the most time and attention are PMTCT and
the “head-to-toe” physical examination. HIV testing re-
quires test kits and other equipment as well as time for
individual counseling on the prevention of HIV trans-
mission and the revelation of test results to others.
Women who test positive for HIV also need to be coun-
seled to join the ART program offered by the facility. As
for the physical exams, they simply take time to
complete. One nurse reported that she could conduct a
total of 10 such examinations in one day. While the
head-to-toe exams take time, both nurses and pregnant
women value them highly.
The physical examination called head-to-toe is usually
done on the first ANC visit, and is used to identify
women with high risk pregnancies as well as check for
any signs of health problems or abnormalities. The rea-
sons for conducting a head to toe examination were ex-
plained by a midwife in a rural facility:
Respondent: Because when you do a head to toe
examination, it is like you have assessed the whole
person, and it is where you find the problems and you
address them. Like when you are doing a head to toe
examination you can see if the woman is healthy; if
the woman is anemic, then you address those issues.
Or like how big is the fetus in relation to the weeks
that the mother is saying.
The nurses interviewed displayed extensive knowledge
about the antenatal services they delivered and the ra-
tionale for each one. For example, they explained why
they gave albendazole for intestinal parasites; they knew
about the importance of screening for anemia and giving
iron supplements; they spoke about tetanus toxoid vac-
cine and when it should be given; they identified the
tests that would be conducted with the blood and urine
samples collected as part of the clinical examination.
They seemed totally familiar with the routine to follow
in counseling and testing for HIV, and for persuading
women to enroll in ART if found positive for HIV
infection.
Nurses begin each ANC clinic with a health education
session for the women and for any spouses who may
have come with their wives. To encourage male involve-
ment in ANC, women who come with their spouses are
served first. The prevention of malaria and the benefits
of SP may be discussed in the health talk. A nurse from
a rural hospital described their health talks related to
malaria prevention in these terms:
Interviewer: So who gives the general health talks?
Respondent: Ourselves.
Interviewer: How do you find the talks?
Respondent: How do I find the talk? The talk begins
like a malaria talk; you say, ‘we are going to talk about
malaria.’ Then we start with malaria, general signs of
malaria, what do you do. What are symptoms? What
are you given when you come and found with
malaria? Then they say if you come when you are not
pregnant they give you quinine or AL Then after that
how can we prevent malaria? So in that topic how can
you prevent malaria is when we introduce that
component of SP.
…
Interviewer: What do you find interesting in this
whole arrangement of teaching people about SP?
Respondent: What I find interesting is that most of
the people already know. They already have the
information about malaria, and when you teach them
you get more information from them. So it is easy, they
understand.
Knowledge of the rationale for IPTp
Respondents considered IPTp as a very important service
delivered within ANC. When asked to rank their services
by importance, the nurses ranked PMTCT first and IPTp
second even though they said that all services were equally
important. The nurses all knew that SP is given to prevent
malaria during pregnancy, and that malaria during preg-
nancy can cause health problems for mother and fetus or
neonate. Some nurses reported that malaria can cause
anemia or premature delivery. A nurse in one rural health
facility located in an area of high malaria prevalence said
that preventing malaria in pregnancy was critical. Speak-
ing of SP, she stated:
It helps because without SP usually here, especially in
this malaria area, there are so many mosquitoes. So
they catch up on malaria so easily when they are
pregnant.…Malaria can cause premature delivery, and
it can cause anemia.
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Several nurses explained why SP is given as a prophy-
laxis; most of them mentioned protecting the mother
and child from malaria, which could lead to miscarriage
or still births. A nurse in an urban facility commented
on giving SP in this manner:
Interviewer: During your diploma training they told
you about SP?
Respondent: Yes
Interviewer: Tell me exactly what.
Respondent: Fansidar (SP) is an antimalarial drug
given to the antenatal mothers. And Fansidar is given
usually in second trimester and the mother should
have a fetal movement. That is when we can give
Fansidar. Starting from 16 weeks above and second
dose is given 28 to 32 weeks.
Interviewer: 28 weeks. So why do they give Fansidar
in particular?
Respondent: Malaria is a major problem for these
mothers. It may lead into abortion or critical
conditions like becoming very sick, and which we do
not want mothers to live in that state. As a result we
are trying to prevent it. That is why we are giving this
Fansidar.
The interviews showed that nurses were well informed
about what constitute a dose of SP, about the need for
giving two doses of SP, and about the negative conse-
quences of malaria in pregnancy. On the other hand, di-
vergences in views were found in the timing of IPTp, in
what guidelines they were to follow, and in the ways to
insist on giving SP as DOT.
Understanding of ministry of health guidelines
The respondents were asked about the guidelines they
followed to provide ANC services and to know how and
when SP should be delivered. A community health nurse
in a rural hospital explained that they have general guide-
lines for reproductive health services and for PMTCT, but
the guidelines were not available in the facility. Nurses in
one hospital were certain that guidelines for malaria pre-
vention existed, but they were not certain where they were
located. No nurse was able to show guidelines for how
IPTp should be delivered in their place of work. Some
nurses reported that they had been told about IPTp by
their colleagues or their supervisor.
Nurses reported that they were trying to follow MOH
guidelines on services, but the guidelines available were
not adequate. They said that PMTCT and IPTp were
two domains of services that were relatively new to
them, and that they lacked direction in how to proceed
with them both. They also expressed concerns about
their inability to follow changes in the policies of the
MOH as they occur. Most of the nurses indicated that
the posters on the walls of the health facility showed
guidelines for the provision of ANC services, but they
were not sufficiently detailed to provide direction. A few
had typed out some of the instructions gleaned from the
posters and hung those instructions on their wall. Sev-
eral ANC units had a few points from the guidelines
posted on the walls that had been typed out by nurses as
reminders of how to proceed.
Most of the nurses providing IPTp services understood
that SP was not to be given during the first trimester,
vaguely defined, and not after 36 weeks of gestation. For
most, the first dose was to be given at 16 weeks (or 18 or
20), or after “quickening,” when a woman becomes aware
of fetal movements. The second dose would then be given
after four weeks or more. A few thought SP could be given
during the first trimester; two mentioned they give the
first dose of SP at 20 weeks. In any case, they knew that
government policy stipulates that they give SP under dir-
ectly observed therapy (DOT).
According to accounts, some nurses rely on quicken-
ing more than on the number of weeks of gestation. A
nurse in an urban hospital explained that after the head-
to-toe examination,
Respondent: … If nothing is detected, then you declare
that particular person to be normal. And then you say:
Any fetal movement? If she says no, you do not give (SP)
even if she is 5 months along. If she has noticed fetal
movement, you do give. And the drugs will be given by
another nurse outside where she will be explained and
usually Fansidar is given as DOT right there.
Interviewer: What do you mean a dot?
Respondent: Directly observed (laughs)
Interviewer: Directly observed, why?
Respondent: Most mothers cannot really manage to
take Fansidar at their homes so we want them to take
it right there.
Interviewer: So mothers cannot take the Fansidar at
their homes? Why do you think?
Respondent: Most of them do not like the drugs. They
are bitter and they say, I do not feel comfortable what,
what. But nowadays they are used to it when we
explain to them.
A nurse in a rural hospital explained her thoughts on
the dosage of SP:
Respondent: We give SP to pregnant women not
because they are suffering from malaria but as a
preventive measure. So they get two doses of SP during
pregnancy.
Interviewer: Two doses means what?
Respondent: Two doses: the first one at 18 weeks; we
give three tablets, and then another one before the end
of 36 weeks.
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Most nurses stated that they would not give SP after
36 weeks of gestation, though one nurse said the upper
limit was 30 weeks. A nurse from a rural government
hospital said that she expected they would soon be giving
more than two doses, for she had heard that government
policy had changed. They were waiting for official notifica-
tion before changing their practice.
Experiences in providing SP
Nurses all sought to persuade women to take the SP pills
as DOT following MOH policy. They insisted that
women take the pills while being observed, for if a dose
of SP is given to women to take at home, the nurses do
not expect that the pills will be taken. As a nurse in a
rural hospital explained:
Respondent: Yes, we first explain. Because they will
always ask, ‘why am I taking this?’ We first explain:
‘you are taking this because you are pregnant, you are
prone to malaria. Malaria has a lot of complications
to your pregnancy.’
Nurses have learned from experience that some women
resist taking SP in the clinic. Women have told nurses that
the pills are hard to swallow because they are large and
bitter tasting. Some women say that SP has side effects,
making them dizzy or nauseous. Others refuse the pills
because they say they have not eaten and do not take
drugs on an empty stomach. Still others state that they
need not take any medication since they are not sick. The
explanation below on how nurses proceed to give SP
comes from a rural health facility, and is similar to many
other explanations offered:
Interviewer: Good. So what are some of the challenges
of giving SP?
Respondent: Maybe the women are not willing to take
it. Most of them refuse because they say, ‘We have not
eaten anything,’ or ‘we are not sick.’ So earlier we were
giving them pills to take home, but now we do DOT:
directly observed therapy. So with DOT we have fewer
problems because we observe the women taking it.
Most of the nurses indicated that they understood the
reluctance of the women to take SP. Several said that
they themselves had trouble swallowing the pills when
they were pregnant because of the bitter taste or that it
made them dizzy. However, they explained that they
would take the time necessary to convince women to
take SP while in the ANC clinic rather than take at
home. Several nurses stated that they encourage the
women to return home quickly after taking SP so they
can eat and drink as soon as possible.
The experience of nurses in providing SP to pregnant
women taught them about the reasons women offered
for initially refusing to take SP, and ways they could per-
suade women to accept the three white pills despite their
bitter taste. Nurses recognized that women were not ac-
customed to taking drugs without food, and that some
were afraid of possible side effects, mainly dizziness and
nausea. Several nurses confessed that they too had
trouble swallowing the pills when they were pregnant.
The way the nurses spoke about the responses of women
when they were asked to take SP indicated that they
understood possible objections, but they still needed to
persuade women to accept SP.
The practice of giving SP as described by respondents
indicated that most of them seek to give two doses of SP
to pregnant women between 16 weeks and 36 weeks of
gestation with at least four weeks between doses. For a
few nurses, the timing of the first dose was a few weeks
later than 16 weeks, and the cut off period was a few
weeks earlier than 36 weeks. They stated that women
who made their first ANC visit in their seventh month
would likely receive only one dose of SP.
Discussion
The findings of this study show that in the facilities vis-
ited, the nurses have been well-trained to provide ANC
services. They are well informed about the ANC services
they provide, and they understand the rationale for the
services. The study also noted the statements of nurses
about their own dedication to their work as nurses and
midwives, and their desire to follow Ministry policy for
the services they provide. All the nurses also spoke
about the problems of understaffing; those working in
rural facilities mentioned shortages of materials and
equipment for the standard provision of ANC services.
Given this positive picture of performance, and the fact
that more than 90 % of pregnant women in Malawi in re-
cent years have made at least two visits to an ANC clinic
(Ministry of Health. National Malaria Treatment Guide-
lines. Lilongwe: National Malaria Control Programme;
2007), how is it that a substantial proportion of pregnant
women have not been receiving the second dose of IPTp
in Malawi? One reason for failure to receive a second dose
seems to be the timing of the first ANC visit. According
to the Malawi Demographic and Health Survey of 2010
(MDHS), only 12 % of pregnant women made an ANC
visit during their first three months of pregnancy, and
36 % made that first visit during their sixth or seventh
month [17]. Women who begin ANC visits in the seventh
month of gestation have a short window of opportunity to
make a second visit before 36 weeks of gestation, the cut
off period mentioned by most nurses. This explanation for
low prevalence of IPTp has also been noted in other stud-
ies of the provision of IPTp in Malawi [11, 12].
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Certain circumstances can also lead to failure to re-
ceive SP. According to the nurses, a woman who is
diagnosed as HIV positive will not be given SP, but
will be invited to enroll in the anti-retroviral program.
The MDHS of 2010 showed that among women with
a live birth in the past three years who had attended
ANC, 10 % were HIV positive. Women who present
with malaria will be referred for treatment and will
not receive SP. A small proportion of women will re-
fuse to take SP and will not be persuaded by the
nurses. Finally, it is logical to assume that some
nurses fail to give a second dose for unspecified rea-
sons when a woman is eligible for SP. Some of the
nurses pointed out that they were sometimes unable
to perform certain tests or provide services because
necessary supplies and/or equipment were unavailable
in the health facility.
Another contributing factor to the level of coverage of
IPTp2 is the uncertainty among nurses about MOH
guidelines for providing SP in ANC clinics. The nurses
all understood that it was MOH policy to provide two
doses of SP to pregnant women, but none of the ANC
clinics visited displayed specific guidelines for giving
IPTp. The policy of the National Malaria Control
Programme to give three doses after the first trimester
that dates from 2007 had clearly not reached these re-
spondents. Most of them understood MOH policy to
mean that they should give the first dose of SP at 16-20
weeks, or after quickening, and the second dose before
36 weeks. A few said they gave the first dose a bit later
than 16-20 weeks, and no second dose after 30 weeks,
indicating some uncertainty about the timing of the
doses of SP. The lack of guidelines displayed in ANC
clinics and the uncertainty of nurses about the timing of
SP doses must contribute to a lack of consistency in giv-
ing a second or third dose of SP.
Part of the explanation for the lack of guidelines
may be that guidelines from various units of the
MOH have not provided the same instructions in the
past for the timing of SP doses. The National Repro-
ductive Health Service Delivery Guidelines of 2007
recommended that IPTp be given at 26 and 32 weeks
of gestation (Ministry of Health. National Reproductive
Health Service Delivery Guidelines. Reproductive Health
Unit. 2007. Unpublished policy document). The National
Malaria Treatment Guidelines of 2007 recommended that
three doses of SP be given four weeks apart after the first tri-
mester (Ministry of Health. National Malaria Treatment
Guidelines. Lilongwe: National Malaria Control Programme;
2007). The Guide for the Management of Malaria of 2007
recommended that two doses of SP be given (Ministry of
Health. Guide for the management of malaria. Lilongwe:
National Malaria Control Programme; 2007). New guide-
lines can resolve those ambiguities.
Limitations
The insights drawn from the study findings would have
added significance had we been able to visit more than
eight facilities. It would also have been useful to systemat-
ically interview the head or manager of each health facility
to discuss their knowledge of MOH policy regarding the
provision of antenatal care and guidelines for IPTp. We
were, however, reassured by the consistency in the reports
of respondents about their own training, their roles and
responsibilities, the provision of ANC services, and their
understanding of the practice of providing IPTp as part of
ANC services.
Conclusion
The accounts of the nurses on their provision of IPTp
services, along with their understanding of MOH policy
on IPTp and their description of the ANC services they
routinely deliver, identify specific challenges in working
toward the improvement of IPTp2 coverage. First, we
should expect that understaffing in some facilities compli-
cates the delivery of appropriate services. Second, some
health care facilities in rural areas do not always have access
to all the drugs and materials and equipment required to
carry out all the tests recommended. Staff shortages are
usually more severe in rural facilities. Third, and above all,
having clear guidelines available in health facilities on the
timing and manner of giving IPTp would facilitate the de-
livery of SP in a more standard and consistent manner. The
lingering ambiguity and uncertainties about the timing of
IPTp leads to variations in how and when SP is delivered.
At the time of the study (2013), Malawi had not yet
adopted the WHO guidelines for IPTp, but the Ministry
of Health has since adopted the WHO guidelines (2014).
Those current guidelines indicate that SP can be given
safely up until delivery, which increases the likelihood of
giving at least two doses of SP to those who initiate ANC
visits late in pregnancy. Training on those guidelines
began in 2014. The adoption of the WHO guidelines, and
their diffusion and discussion in all health care facilities in
the country, can be expected to increase the coverage of
IPTp2 in Malawi.
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